Silverarc Capital Management, LLC Pliant Therapeutics, Inc. Transaction History

Silverarc Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$14.14 - $19.59 $1.91 Million - $2.65 Million	-135,132 Reduced 42.42%	183,392 $2.73 Million
Q4 2023 Feb 14, 2024	BUY	$12.85 - $19.15 $875,277 - $1.3 Million	68,115 Added 27.2%	318,524 $5.77 Million
Q3 2023 Nov 13, 2023	BUY	$14.58 - $20.15 $2.09 Million - $2.88 Million	143,142 Added 133.44%	250,409 $4.34 Million
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $131,678 - $222,079	7,267 Added 7.27%	107,267 $1.94 Million
Q1 2023 May 15, 2023	SELL	$18.73 - $36.26 $2.2 Million - $4.26 Million	-117,503 Reduced 54.02%	100,000 $2.66 Million
Q4 2022 Feb 14, 2023	BUY	$17.0 - $25.43 $130,577 - $195,327	7,681 Added 3.66%	217,503 $4.2 Million
Q3 2022 Oct 28, 2022	BUY	$7.67 - $24.23 $1.61 Million - $5.08 Million	209,822 New	209,822 $4.38 Million

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.